Frequently asked questions Question 1How do biomarkers help in diagnosis and treating Alzheimer’s disease? Question 2What sets LC-MS apart from traditional immunoassays in Alzheimer’s disease diagnosis? Question 3 What are the likely advancements in brain health testing? Question 4What’s C2N’s role in Alzheimer’s disease staging innovation? Question 5How does C2N improve early Alzheimer’s disease detection? Question 6What makes blood biomarkers vital for Alzheimer’s disease prevention trials?
